Pharmaceutical compositions of spirooxindole compound for topical administration and their use as therapeutic agents

Details for Australian Patent Application No. 2011220396 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Winters, Conrad Stewart; Yang, Meidong; Chen, Haigang

Agent Davies Collison Cave

Pub. Number AU-A-2011220396

PCT Pub. Number WO2011/106729

Priority 61/308,759 26.02.10 US

Filing date 25 February 2011

Wipo publication date 1 September 2011

International Classifications

A61K 9/06 Medicinal preparations characterised by special physical form - Ointments

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/02 Drugs for disorders of the nervous system

A61P 25/06 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/106729 Priority application(s): WO2011/106729

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011220397-Structures with surface-embedded additives and related manufacturing methods

2011220389-Systems and methods for using negative pressure wound therapy to manage open abdominal wounds